270 related articles for article (PubMed ID: 16639730)
1. Association between adiponectin, insulin resistance, and endometrial cancer.
Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH
Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
3. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
4. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
6. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
[TBL] [Abstract][Full Text] [Related]
7. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
8. [Serum changes of adiponectin, insulin resistance and their correlation in endometrial cancer patients].
Fu JR; Lu LN; Yu LP; Wang DY; Ding KS
Zhonghua Fu Chan Ke Za Zhi; 2012 Sep; 47(9):672-5. PubMed ID: 23141290
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance: an independent risk factor for lung cancer?
Petridou ET; Sergentanis TN; Antonopoulos CN; Dessypris N; Matsoukis IL; Aronis K; Efremidis A; Syrigos C; Mantzoros CS
Metabolism; 2011 Aug; 60(8):1100-6. PubMed ID: 21251684
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
Saltzman BS; Doherty JA; Hill DA; Beresford SA; Voigt LF; Chen C; Weiss NS
Am J Epidemiol; 2008 Mar; 167(5):607-14. PubMed ID: 18071194
[TBL] [Abstract][Full Text] [Related]
12. [Obesity at different ages and endometrial cancer risk factors in urban Shanghai, China].
Xu W; Dai Q; Ruan Z; Cheng J; Jin F; Shu X
Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):347-51. PubMed ID: 12482364
[TBL] [Abstract][Full Text] [Related]
13. Weight history and risk of endometrial cancer among Chinese women.
Xu WH; Xiang YB; Zheng W; Zhang X; Ruan ZX; Cheng JR; Gao YT; Shu XO
Int J Epidemiol; 2006 Feb; 35(1):159-66. PubMed ID: 16258056
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
Michalakis K; Williams CJ; Mitsiades N; Blakeman J; Balafouta-Tselenis S; Giannopoulos A; Mantzoros CS
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):308-13. PubMed ID: 17301264
[TBL] [Abstract][Full Text] [Related]
16. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
17. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
18. [Serum adiponectin levels in patients with acromegaly].
Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
[TBL] [Abstract][Full Text] [Related]
19. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin and gastric cancer.
Ishikawa M; Kitayama J; Kazama S; Hiramatsu T; Hatano K; Nagawa H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):466-72. PubMed ID: 15701829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
